CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

USPTO Patent Application US 2017/0014367 A2
Application Date: Jan. 19th, 2017

ABSTRACT

The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other...
Application Number:
14/209,480
International Classification:
A61K 31/225 (20060101); A61K 9/48 (20060101); A61K 9/20 (20060101); A61K 9/28 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1-90. (canceled)

DESCRIPTION

FIELD OF THE INVENTION

The present invention relates to controlled release pharmaceutical compositions comprising a fumaric acid ester as an active substance. The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designed to release the fumaric acid ester in a controlled manner...
Back to Top